Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
 
 
October 23, Monday 2017 10:45 PM       

       HEADLINES: Girl jumps from school building, dies                                              Body found in tunnel most likely of missing Indian girl, says Texas police                                              Body of youth recovered from Neyyar                                              Teen jumps to death in Kollam, clash in SFI march                                              HC postpones Rahul Easwar’s arrest till Thursday                                              Patidar leader alleges BJP bribed him                                              ISRO eyes Cartosat-2 series launch in Dec                                              Bilkis Bano case: Gujarat to apprise SC on departmental action                                              Polls in Himachal earlier due to weather: CEC                                              Abbasi becomes first Pak PM to fly military helicopter                                              First batch of Afghan Pilots complete 'Black Hawk' training in US                                              Small child's body found in culvert in Texas                                              School sports meet: Ernakulam secures top spot                                              School sports meet: Mar Basil becomes champion in schools division                                              ‘Uncapped’ Shreyas Iyer, Mohammed Siraj named in India T20I squad                                              Ashwin, Jadeja recalled for Test series against Lanka                                              FIFA U-17 World Cup semi-final match to take place in Kolkata                                              Kaumudi Facebook
       SCI&TECH Next Article: Threat of asteroid impact looming over Earth: experts  
       New drug to treat blood cancer developed
 
         Posted on :19:38:19 Jun 10, 2017
   
A A
       Last edited on:19:38:19 Jun 10, 2017
         Tags: New drug, blood cancer
 
NEW YORK: A new drug for blood cancer that may provide better treatment alone or combined with chemotherapy has been developed by a team led by an Indian-origin scientist.
 
Acute lymphoblastic leukemia or ALL can affect both children and adults.
 
Scientists have found up to 30 per cent of adult ALL patients have what is called a Philadelphia chromosome, where two segments of chromosomes have aberrantly fused together. The ALL cancer cells containing the Philadelphia chromosome are addicted to repairing DNA.
 
"Repairing DNA may sound like a good thing when you are talking about healthy cells. But in this case it is a bad thing. When you treat these leukemia cells with chemotherapy, you want DNA damage to accumulate so the cancer cells will die," said Srividya Bhaskara, a post doctoral at University of Utah in the US.
 
"However, because the Philadelphia chromosome continually causes repair, these cells do not retain enough DNA damage to die. Essentially they resist any kind of drug you use on them. So we had to find a new way to overcome this DNA repair addiction," she said.
 
Researchers found that the Philadelphia chromosome promotes repair through numerous proteins. But putting together a cocktail of drugs to inhibit them all would likely be too toxic and affect normal cells.
 
Bhaskara focused on two specific proteins she found were directly involved in DNA repair, called histone deacetylases (HDAC) 1 and 2. She then collaborated with a company to make a drug that inhibits HDAC1,2 activity.
 
After a comprehensive analysis of how the drug worked, Bhaskara tested the HDAC1,2 inhibitor in patient samples and mice and saw encouraging results, either alone or in combination with a chemotherapy drug called doxorubicin.
 
Doxorubicin is one of the components of the chemotherapy cocktail regimen currently used for Philadelphia chromosome-positive ALL patients.
 
Researchers found that the drugs broke down the central hub of DNA repair, and the HDAC1,2 inhibitor actually reduced different repair protein functions.
 
"The treated mice did not get sick from the drug, and we did not see any apparent toxic side-effects in them. And when the drug was combined with a low concentration of doxorubicin, it had additional therapeutic benefits," Bhaskara said.
 
"We actually show in the patient-derived mouse models that using the combination of drugs, or HDAC1,2 inhibitor alone, is sufficient to decrease the leukemia load," she said.
 
Leukemia is a white blood cell disease where the body produces too many white and not enough red blood cells.
 
When the mice in this study were treated with the HDAC1,2 inhibitor or the HDAC1,2/doxorubicin combination, their bone marrow started turning from pale to red, indicating the white blood cells were being replaced with red blood cells, researchers said.
 
"We completely nailed down how the HDAC1,2 inhibitor affects DNA repair. This is so important, not just for this cancer, but any cancer that is repair-addicted. We know there is a specific type of lymphoma that is also repair-addicted," Bhaskara said.
 
The study was published in the journal Leukemia.
A A
       SCI&TECH
Next Article: Threat of asteroid impact looming over Earth: experts
 
 
SCI&TECH HEADLINES
Gamma rays will reach beyond limits of light: Researchers  
Suicide molecules may help combat cancer: Study  
Aspirin a day may keep liver cancer away  
Clearing the myths about osteoporosis  
Stress as unhealthy as junk food  
Planet Nine does exist in solar system: NASA  
Blame these hormones if your dog is getting aggressive  
Save big on Infinix Note 4, Hot 4 Pro during Flipkart's 'Big Diwali Sale'  
Even modest exposure to oil can harm coastal, marine birds  
Starfish, anemones protect ecosystems from climate change  
Skipping breakfast may help to shed those extra kilos  
Dozing off during lecture? Blame your neurons  
Google's Pixel 2 promotes safe driving through automatic 'do not disturb' mode  
Researchers create molecule that could kill HIV  
Google unveils new moves to boost struggling news organizations  
Here's how zebrafish get its stripes  
Facebook to introduce facial recognition for account security  
LG launches smartphone to 'keep mosquitos at bay'  
New spider species named after DiCaprio, Obama  
Astrophysicists make music from Saturn's moons, rings  
Rooter includes Kabbadi, F1 under one roof  
Orbiting supermassive black holes discovered for first time  
Theweightmonitor.com launches mobile app for easier access to one-stop weight management platform  
New drug to treat blood cancer developed  
Threat of asteroid impact looming over Earth: experts  
 
Should Kummanam apologise to Kerala as remarked by the CM?
yes
 
no
 
no opinion
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy